My watch list
my.bionity.com  
Login  

364 Current news from the ressort manufacturing

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
3D printing of tablets

Merck and AMCM cooperate

28-Feb-2020

Merck and AMCM, Starnberg, Germany, announced a cooperation agreement on the 3D printing of tablets. AMCM offers customized additive manufacturing solutions. The cooperation targets GMP-conform (Good Manufacturing Practice) tablet formulation development and production for clinical trials in a ...

more

image description
Merck Invests in State-Of-The-Art Biotech Development Facility in Switzerland

28-Jan-2020

Merck announced an investment of €250million in a new facility in Corsier-sur-Vevey, Switzerland – the Merck Biotech Development Center – dedicated to biotech development and manufacturing for clinical studies. Driven by the growth of the Healthcare business sector R&D pipeline, this investment ...

more

image description
GE Healthcare Life Sciences plans new manufacturing facility in Switzerland

21-Jan-2020

GE Healthcare Life Sciences is building a new 7,360 square meter facility in Grens, Switzerland, in the new Signy Park, for the manufacture of single use kits for the Sepax and Sefia cell processing systems. The facility will meet global regulatory requirements and is expected to be fully ...

more

Eppendorf significantly expands production site in Oldenburg

27-Sep-2019

The Eppendorf Group is boosting its production capacity at its site in Oldenburg in Holstein by building two new production halls. Operations at the two sites will begin in the second half of 2020, significantly increasing the overall capacity of Eppendorf Polymere GmbH, a wholly owned subsidiary ...

more

Lonza Expands Bioconjugation Facility and Announces Approval of Third Commercial ADC

24-Jul-2019

Lonza announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a third antibody-drug-conjugate (ADC) produced at the site. Building on 12 years of experience in the exacting bioconjugation space, Lonza’s expansion ...

more

FUJIFILM Irvine Scientific constructs new cell culture media manufacturing site in Europe

03-Jul-2019

FUJIFILM Irvine Scientific, Inc. announced plans to open a third manufacturing facility located in Tilburg, Netherlands. The company currently has sites in the United States and Japan. Fujifilm’s investment in this project demonstrates its commitment to accelerate development in bioproduction ...

more

Pharmaceutical Production with Reduced Waste

Platform technology for producing cephalosporin antibiotics

18-Jun-2019

Antibiotics save countless human lives – modern medicine without them is unimaginable. The largest proportion by volume of industrially produced antibiotics today are cephalosporins, structural variants of the first antibiotic, penicillin. Unfortunately, their production generates a considerable ...

more

image description
Vetter Works Towards a Sustainable Energy Supply

All German sites of the pharmaceutical service provider will be supplied with green electricity moving forward

31-May-2019

Vetter has reached another important milestone regarding sustainability. Beginning immediately, all German sites of the company will be supplied with only CO2 neutral energy from certified renewable energy sources. This action underlines the CDMO’s commitment to climate and environmental ...

more

Thermo Fisher Scientific to Invest $50 Million to Expand Bioproduction Capabilities

22-May-2019

Thermo Fisher Scientific Inc. announced that it is investing more than $50 million in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioprocess container (BPC) systems. Thermo Fisher's single-use technologies are used for critical, sterile ...

more

image description
Merck Invests in Expansion of Manufacturing Capacity for Biotech Medicines

€150 million investment over the 2019-2023 period in manufacturing site at Aubonne, Switzerland

28-Mar-2019

Merck announced an investment of €150 million (165 million Swiss francs) in its manufacturing site at Aubonne, Switzerland, to expand manufacturing capacity for its biotech medicines. The investment will cover a new building dedicated to Merck biotech medicines destined for more than 150 ...

more

Page 2 From 37
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE